Understanding the impact of group 2 innate lymphoid cells on airway epithelial regeneration and repair

了解第 2 组先天淋巴细胞对气道上皮再生和修复的影响

基本信息

  • 批准号:
    10387545
  • 负责人:
  • 金额:
    $ 4.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Epithelial dysfunction is critical in the pathogenesis of human conducting airway diseases such as COPD and asthma. Immune cells are known to influence epithelial composition and function in a variety of tissues. Group 2 innate lymphoid cells (ILC2s) are immune cells that have recently been shown to promote epithelial repair in the lung parenchyma in several murine injury models by promoting growth of distal facultative epithelial progenitors. While hyperactive ILC2s in the airway are known to contribute to chronic airway inflammation, the role of ILC2s in regulating epithelial regeneration and repair in the airway is unknown. To address this gap in knowledge, we will study ILC2s in the context of epithelial injury in the mouse trachea, which models the biology of the human conducting airways. Normal epithelial repair in the trachea occurs via expansion and differentiation of basal stem cells that give rise to all airway epithelial lineages. We will test the hypothesis that ILC2s contribute to airway epithelial repair by regulating proliferation and differentiation of basal cells. We hypothesize that the epithelial alarmin interleukin-33 (IL-33) is a critical signaling factor that initiates immune cell activation during airway regeneration and repair. Aim 1 will characterize the ILC2 response to airway injury and determine whether ILC2s are required for effective epithelial repair. Aim 2 will examine the IL-33/ST2 signaling axis as a potential mechanism by which immune cells respond to injury and promote repair. Targeted transgenic deletion and manipulation of ILC2s will provide cell-specific evidence of ILC2 involvement in airway epithelial regeneration. Interrogation of intracellular phosphorylation events and cytokine production will further elucidate the signaling mechanisms that promote epithelial remodeling and regeneration. Understanding the mechanisms of ILC2 activation and regulation of airway epithelial function will contribute to our understanding of human airway biology and provide potential targets for the therapeutic immunomodulation of human airway diseases.
摘要 上皮功能障碍在人类传导性气道疾病如COPD和COPD的发病机制中是关键的。 哮喘已知免疫细胞影响各种组织中的上皮组成和功能。组 2先天淋巴细胞(ILC 2)是一种免疫细胞,最近被证明可以促进上皮修复。 通过促进远端兼性上皮细胞生长在几种小鼠肺损伤模型中的肺实质 祖先虽然已知气道中的过度活跃的ILC 2会导致慢性气道炎症,但 ILC 2在调节气道上皮再生和修复中的作用尚不清楚。为了弥补这一差距, 知识,我们将在小鼠气管上皮损伤的背景下研究ILC 2,其模拟了 人体呼吸道的生物学气管中的正常上皮修复通过扩张发生, 基础干细胞的分化产生所有气道上皮谱系。我们将检验这个假设, ILC 2通过调节基底细胞的增殖和分化促进气道上皮修复。我们 假设上皮警报素白细胞介素-33(IL-33)是启动免疫应答的关键信号因子, 在气道再生和修复过程中的细胞活化。目的1将描述ILC 2对气道损伤的反应 并确定ILC 2是否是有效的上皮修复所必需的。目的2将检查IL-33/ST 2 信号轴作为免疫细胞对损伤做出反应并促进修复的潜在机制。针对性 ILC 2的转基因缺失和操作将提供ILC 2参与气道炎症的细胞特异性证据。 上皮再生细胞内磷酸化事件和细胞因子产生的询问将进一步 阐明促进上皮重塑和再生的信号机制。了解 ILC 2激活和调节气道上皮功能的机制将有助于我们理解 并为人类气道的治疗性免疫调节提供了潜在的靶点 疾病

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexandra Ysasi其他文献

Alexandra Ysasi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexandra Ysasi', 18)}}的其他基金

Understanding the impact of group 2 innate lymphoid cells on airway epithelial regeneration and repair
了解第 2 组先天淋巴细胞对气道上皮再生和修复的影响
  • 批准号:
    10683709
  • 财政年份:
    2022
  • 资助金额:
    $ 4.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了